Mkts

Immunocore Holdings plc

NASDAQ: IMCR
$26.41-0.22 (-0.83%)
As of Nov 20, 4:00 PM ET

Key statistics

Day range
25.6126.82
52-week range
27.3140.71
Today
Open26.37
Previous close26.41
Volume—
Valuation
Market cap1.38B
P/E ratio—
EPS (TTM)-0.37
Income & risk
Dividend / yield—
Beta0.87
Avg volume455.4K
Discussion

IMCR News

Stories mentioning IMCR from around the web — every one is an open thread, so give it a like or add your take.

All news →

Loading news…

Financial statements

Financial statements

As filed, straight from the 10-Q — up to 19 years of history, free, with every line item chartable.

Line itemQ1 '26Mar 31Q4 '25Dec 31Q3 '25Sep 30Q2 '25Jun 30Q1 '25Mar 31Q4 '24Dec 31Q3 '24Sep 30Q2 '24Jun 30
Income Statement
Revenue106,677104,478103,69397,96493,88184,05280,24875,400
Cost of Goods Sold434.002,703513.001,040831.00330.00448.001,707
Gross Profit106,243101,775103,18096,92493,05083,72279,80073,693
Operating Expenses
Research & Development61,11378,82170,57269,00856,46860,85052,77051,072
Sales General & Admin37,85042,64539,77942,79140,19842,32435,53238,638
Total Operating Expenses
Operating Income (Loss)7,280(19,691)(7,171)(14,875)(3,616)(19,452)(8,502)(16,017)
Interest Income3,4183,9064,1234,2714,1765,1735,9606,239
Interest Expense
Other Expense1,7764,5045,0624,6935,469993.008,9624,433
Pretax Income13,272(15,794)304.00(9,694)6,084(24,821)6,093(10,130)
Tax Provision301.0014,266481.00606.001,061(1,050)(2,643)1,486
Net Income (Loss)12,971(30,060)(177.00)(10,300)5,023(23,771)8,736(11,616)
Earnings Per Share (Basic)0.26(0.60)0.00(0.20)0.10(0.48)0.17(0.23)
Earnings Per Share (Diluted)0.25(0.60)0.00(0.20)0.10(0.48)0.17(0.23)
Weighted Average Shares Outstanding (Basic)50,75550,34650,40450,29450,08749,99150,02250,014
Weighted Average Shares Outstanding (Diluted)52,93550,34650,40450,29451,95049,99152,80850,014

Scroll the table sideways for older periods — the line-item column and the period header stay put. Hover a row and use the chart handle to plot it over the full history.

Key facts

About IMCR

Immunocore Holdings plc (NASDAQ: IMCR) is a stock listed on the Nasdaq Stock Market under the ticker symbol IMCR. It last traded at $26.41 (Nov 20, 2026, 4:00 PM ET), down 0.8% on the day. That gives Immunocore a market capitalisation of $1.4B.

Over the past 52 weeks IMCR has traded between $27.31 and $40.71.

Revenue for the quarter ended Mar 31, 2026 was $106.7M; net income $13.0M. Revenue was up 13.6% from $93.9M in the quarter ended Mar 31, 2025.

Last 4 quarters
Quarter endedRevenueNet incomeMargin
Mar 31, 2026$106.7M$13.0M12.2%
Dec 31, 2025$104.5M-$30.1M-28.8%
Sep 30, 2025$103.7M-$177.0K-0.2%
Jun 30, 2025$98.0M-$10.3M-10.5%

From Immunocore’s quarterly (10-Q) filings, in US dollars.

Latest News

Market news from around the web — every story is an open thread, so give it a like or add your take.

All news →

Loading news…